In Brief: Incyte/Vysis/Genome Systems
Executive Summary
Incyte/Vysis/Genome Systems: Enter three-year collaboration to develop comprehensive genomic map that identifies chromosomal locations for human gene sequences. Palo Alto, Calif.-based Incyte will provide its proprietary DNA clones of expressed gene sequences; Genome Systems of St. Louis will map the gene sequences against their bacterial artificial chromosome library; and Downers Grove, Ill.-based Vysis physically will locate and map the genes to their chromosome locations using their Fluorescence In-Situ Hybridization technology. Incyte also announces it is acquiring Genome Systems, including Vysis' equity position in the company...